- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SonoSite and ATL pair ultrasound system sales
ATL Ultrasound will be able to bundle sales of the SonoSite 180 handheld ultrasound system with its own ultrasound systems, thanks to a contract revision signed this month.The agreement removes an exclusivity provision of a January 1999 contract and
ATL Ultrasound will be able to bundle sales of the SonoSite 180 handheld ultrasound system with its own ultrasound systems, thanks to a contract revision signed this month.
The agreement removes an exclusivity provision of a January 1999 contract and enables ATL, a Philips Medical Systems company, to include the SonoSite 180 system with sales of its ultrasound systems. In addition, it allows SonoSite to sell products to private offices as well as hospitals.
The agreement was necessary because SonoSite restructured a distribution contract with PSS World Medical that was signed last year. SonoSite struck an exclusive distributor agreement with PSS World Medical subsidiary Diagnostic Imaging for SonoSite 180 in the private-practice market (SCAN 8/4/99).
ATL produces a line of ultrasound machines called HDI, for high definition imaging, while SonoSite develops, sells, and manufactures a 5-pound handheld digital ultrasound system. The SonoSite 180 system was developed using licensed ATL technology and part of the SonoSite system is manufactured by ATL, said Tim Mickelson, president and CEO of ATL Ultrasound.
The 19 member countries of NATO will purchase the SonoSite 180 handheld ultrasound system for use on the battlefield (SCAN 4/12/00).
SonoSite and ATL Ultrasound signed a similar agreement in March of this year giving ATL exclusive rights to include SonoSite's SonoHeart handheld echocardiology device with sales of its own HDI ultrasound systems and with cardiac catheterization systems from Philips Medical Systems. The SonoHeart agreement covers the distribution of products in cardiology-related segments worldwide, with the exception of Japan. Distribution in Japan is covered under an agreement with Olympus Optical.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
